rs1432862

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001447.3(FAT2):​c.1720C>T​(p.Arg574Cys) variant causes a missense change. The variant allele was found at a frequency of 0.503 in 1,613,572 control chromosomes in the GnomAD database, including 207,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R574H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.48 ( 18000 hom., cov: 32)
Exomes 𝑓: 0.51 ( 189845 hom. )

Consequence

FAT2
NM_001447.3 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.76

Publications

27 publications found
Variant links:
Genes affected
FAT2 (HGNC:3596): (FAT atypical cadherin 2) This gene is the second identified human homolog of the Drosophila fat gene, which encodes a tumor suppressor essential for controlling cell proliferation during Drosophila development. The gene product is a member of the cadherin superfamily, a group of integral membrane proteins characterized by the presence of cadherin-type repeats. In addition to containing 34 tandem cadherin-type repeats, the gene product has two epidermal growth factor (EGF)-like repeats and one laminin G domain. This protein most likely functions as a cell adhesion molecule, controlling cell proliferation and playing an important role in cerebellum development. [provided by RefSeq, Jul 2008]
FAT2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 45
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Illumina, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021697283).
BP6
Variant 5-151567212-G-A is Benign according to our data. Variant chr5-151567212-G-A is described in ClinVar as Benign. ClinVar VariationId is 1249058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.523 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT2NM_001447.3 linkc.1720C>T p.Arg574Cys missense_variant Exon 2 of 24 ENST00000261800.6 NP_001438.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT2ENST00000261800.6 linkc.1720C>T p.Arg574Cys missense_variant Exon 2 of 24 1 NM_001447.3 ENSP00000261800.5

Frequencies

GnomAD3 genomes
AF:
0.484
AC:
73489
AN:
151866
Hom.:
17987
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.439
Gnomad AMI
AF:
0.354
Gnomad AMR
AF:
0.446
Gnomad ASJ
AF:
0.531
Gnomad EAS
AF:
0.348
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.553
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.528
Gnomad OTH
AF:
0.487
GnomAD2 exomes
AF:
0.466
AC:
116880
AN:
251070
AF XY:
0.468
show subpopulations
Gnomad AFR exome
AF:
0.434
Gnomad AMR exome
AF:
0.340
Gnomad ASJ exome
AF:
0.529
Gnomad EAS exome
AF:
0.359
Gnomad FIN exome
AF:
0.550
Gnomad NFE exome
AF:
0.531
Gnomad OTH exome
AF:
0.507
GnomAD4 exome
AF:
0.505
AC:
738745
AN:
1461588
Hom.:
189845
Cov.:
60
AF XY:
0.502
AC XY:
364928
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.435
AC:
14568
AN:
33474
American (AMR)
AF:
0.352
AC:
15729
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.535
AC:
13982
AN:
26126
East Asian (EAS)
AF:
0.324
AC:
12851
AN:
39700
South Asian (SAS)
AF:
0.362
AC:
31248
AN:
86216
European-Finnish (FIN)
AF:
0.546
AC:
29152
AN:
53394
Middle Eastern (MID)
AF:
0.463
AC:
2672
AN:
5768
European-Non Finnish (NFE)
AF:
0.529
AC:
587985
AN:
1111824
Other (OTH)
AF:
0.506
AC:
30558
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
22384
44769
67153
89538
111922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16570
33140
49710
66280
82850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.484
AC:
73527
AN:
151984
Hom.:
18000
Cov.:
32
AF XY:
0.481
AC XY:
35715
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.438
AC:
18168
AN:
41436
American (AMR)
AF:
0.445
AC:
6799
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
1843
AN:
3468
East Asian (EAS)
AF:
0.348
AC:
1799
AN:
5174
South Asian (SAS)
AF:
0.362
AC:
1742
AN:
4816
European-Finnish (FIN)
AF:
0.553
AC:
5828
AN:
10548
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.528
AC:
35860
AN:
67964
Other (OTH)
AF:
0.483
AC:
1020
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1933
3867
5800
7734
9667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
664
1328
1992
2656
3320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.509
Hom.:
68324
Bravo
AF:
0.475
TwinsUK
AF:
0.518
AC:
1922
ALSPAC
AF:
0.531
AC:
2045
ESP6500AA
AF:
0.439
AC:
1936
ESP6500EA
AF:
0.523
AC:
4501
ExAC
AF:
0.467
AC:
56713
Asia WGS
AF:
0.384
AC:
1335
AN:
3478
EpiCase
AF:
0.526
EpiControl
AF:
0.531

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FAT2-related disorder Benign:1
Jul 08, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Spinocerebellar ataxia 45 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.47
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Uncertain
0.24
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.85
D
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
6.8
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.28
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.0080
D
Polyphen
0.99
D
Vest4
0.094
MPC
0.52
ClinPred
0.033
T
GERP RS
4.3
Varity_R
0.33
gMVP
0.53
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1432862; hg19: chr5-150946773; COSMIC: COSV55815795; API